ScandiBio Therapeutics

info@scandibio.com
  • About Us
    • Our Science
    • Scientific rationale
    • The Team
  • Clinical Studies
    • Phase I/II: SERINE
    • Phase I: METABOLIC COFACTORS
    • Phase II: NAFLD
    • Phase II: AD/PD
    • Phase II: COVID-19
    • Phase III: COVID-19
  • Publications
  • News
  • Contact

Yearly Archives: 2020

ScandiBio Therapeutics   →  2020
06
Oct
Date October 6, 2020
Categories News

Phase 2 human clinical trial shows that metabolic activators reduces recovery time in COVID-19 patients by nearly 30%

ScandiBio Therapeutics has completed a Phase II study based on treatment of patients with COVID-19. Patients with mild-to-moderate...
Read More
Author SCANDIBIO
24
Jul
Date July 24, 2020
Categories News

A review article has been published discussing the current status of COVID-19 therapies

A review paper has been published in the journal iScience about the use of drug repositioning applications in treatment of COVID-1...
Read More
Author SCANDIBIO
08
Jul
Date July 8, 2020
Categories News

A review article has been published regarding the host-microbiome interactions in neurodegenerative diseases

A review paper has been published in the journal Frontiers in Neuroscience discussing the use of AI-based systems biology approach...
Read More
Author SCANDIBIO
01
Jun
Date June 1, 2020
Categories News

ScandiBio Therapeutics has completed a directed share issue amounting to 5 million SEK

The Board of Directors of ScandiBio Therapeutics has, in accordance with the issue authorization granted by the extraordinary gene...
Read More
Author SCANDIBIO
19
May
Date May 19, 2020
Categories News

A review article has been published about the use of AI-based systems biology for drug development to treat neurodegenerative diseases

A review paper has been published in the journal Drug Discovery Today discussing the use of systems biology approaches for studyin...
Read More
Author SCANDIBIO
15
May
Date May 15, 2020
Categories News

A phase II study in COVID-19 patients using CMCS been initiated

ScandiBio Therapeutics has initiated a Phase II study in patients with COVID-19 using Combined Metabolic Cofactors Supplementation...
Read More
Author SCANDIBIO
27
Apr
Date April 27, 2020
Categories News

The results of a phase I study of CMCS have been published

The results of a Phase I study have been published in the journal Molecular Systems Biology describing the kinetics of the Combine...
Read More
Author SCANDIBIO
23
Mar
Date March 23, 2020
Categories News

An article has been published how to address the heterogeneity in liver diseases with AI-based genome metabolic modeling

An article has been published in Briefings in Bioinformatics about the heterogeneity in liver diseases. The abnormalities in human...
Read More
Author SCANDIBIO
03
Feb
Date February 3, 2020
Categories News

A phase II study in patients with Alzheimer’s and Parkinson’s Diseases has been initiated

ScandiBio Therapeutics has initiated a Phase II study in patients with Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) u...
Read More
Author SCANDIBIO
15
Jan
Date January 15, 2020
Categories News

A phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) has been initiated

ScandiBio Therapeutics has initiated a Phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) using Combined M...
Read More
Author SCANDIBIO

Categories

  • News 16

Recent Posts

  • Metabolic Activators Therapy Improve Liver Fat in NAFLD PatientsOctober 25, 2021
  • Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Parkinson’s disease patientsAugust 5, 2021
  • Phase 2 human clinical trial shows that metabolic activators improve cognitive function in Alzheimer’s disease patientsJuly 20, 2021
  • The results of a phase II and III clinical trials about the treatment of COVID-19 patients with CMAs have been published at Advanced ScienceJune 29, 2021
  • Phase 3 human clinical trial shows that metabolic activators accelerates recovery in COVID-19 patientsFebruary 24, 2021

Archives

  • October 2021
  • August 2021
  • July 2021
  • June 2021
  • February 2021
  • October 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
Copyright © 2020 ScandiBio Therapeutics. All rights reserved.